What is Acadia Pharmaceuticals's total revenue?

Acadia Pharmaceuticals (ACAD) reported total revenue of $268.06M in Q1 2026.

How has Acadia Pharmaceuticals's total revenue changed year-over-year?

Acadia Pharmaceuticals's total revenue increased by 9.7% year-over-year, from $244.32M to $268.06M.

What is the long-term trend for Acadia Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), Acadia Pharmaceuticals's total revenue has grown at a 22.0% compound annual growth rate (CAGR), from $484.15M to $1.07B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Acadia Pharmaceuticals ACAD Total Revenue

Total Revenue at other companies

BiogenBIIB

$2.48B+1.9%

Neurocrine BiosciencesNBIX

$814.5M+42.2%

Catalyst PharmaceuticalCPRX

$149.39M+5.6%

PTC TherapeuticsPTCT

$272.55M-76.8%

BridgeBio PharmaBBIO

$194.52M+66.8%

TG TherapeuticsTGTX

$204.92M+69.6%

Segments

By product

See full

Nuplazid$166.92M+4.5%

Daybue$101.14M+19.6%

By segment

See full

Reportable Segment Aggregation Before Other Operating$268.06M+9.7%

Other financials

Income statement

See full

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's total revenue?: Acadia Pharmaceuticals (ACAD) reported total revenue of $268.06M in Q1 2026.
How has Acadia Pharmaceuticals's total revenue changed year-over-year?: Acadia Pharmaceuticals's total revenue increased by 9.7% year-over-year, from $244.32M to $268.06M.
What is the long-term trend for Acadia Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), Acadia Pharmaceuticals's total revenue has grown at a 22.0% compound annual growth rate (CAGR), from $484.15M to $1.07B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.